Please use this identifier to cite or link to this item: https://swslhd.intersearch.com.au/swslhdjspui/handle/1/12634
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPeng, D.-
dc.contributor.authorKelly, A.-
dc.contributor.authorBrady, B.-
dc.contributor.authorFaasse, K.-
dc.contributor.authorEl-Haddad, C.-
dc.contributor.authorFrade, S.-
dc.date.accessioned2024-03-11T01:57:40Z-
dc.date.available2024-03-11T01:57:40Z-
dc.date.issued2024-
dc.identifier.issn07383991 (ISSN)-
dc.identifier.urihttps://swslhd.intersearch.com.au/swslhdjspui/handle/1/12634-
dc.description.abstractObjective: People with autoimmune and inflammatory rheumatic disease (AIIRD) are at an increased risk of morbidity from COVID-19. While COVID-19 vaccination is effective at reducing disease complications, there have been significant levels of vaccine hesitancy in people with AIIRD. We aimed to understand vaccine hesitancy and promote shared decision-making by describing the experiences and perspectives of people with AIIRD who had concerns with COVID-19 vaccinations. Methods: Adults with AIIRD on immunosuppressive medications who expressed concerns regarding the COVID-19 vaccination were purposively sampled until thematic saturation. Individual semi-structured interviews were conducted and analysed using reflexive thematic analysis. Results: Sixteen adults with an AIIRD were interviewed. Thematic analysis yielded four themes: heightened sense of vulnerability; determining individual suitability; desperate for freedom and relief; deterred by scepticism. Conclusions: The perspectives of people with AIIRD towards the COVID-19 vaccination were shaped by a sense of vulnerability. The decision-making experience was challenging, resulting from struggles with handling information, dealing with external pressures, and facing negativity. Practice Implications: A collaborative approach, involving close family and friends and avoiding negativity and pressure can improve engagement and support decision-making around COVID-19 vaccination. Clearly addressing potential risks of vaccination may prevent subsequent regret and hesitancy if they arise. © 2023 The Authors-
dc.publisherElsevier Ireland Ltd-
dc.subjectAutoimmune diseases COVID-19 Rheumatic Disease Vaccination Vaccine hesitancy Adult COVID-19 Vaccines Decision Making, Shared Humans Rheumatic Diseases SARS-CoV-2 vaccine aged Article Australia autoimmune disease clinical article collaborative learning family support female human immunosuppressive treatment male risk assessment semi structured interview shared decision making thematic analysis coronavirus disease 2019-
dc.titlePerspectives and experiences of COVID-19 vaccination in people with autoimmune and inflammatory rheumatic disease-
dc.typeJournal Article-
dc.contributor.swslhdauthorPeng, David-
dc.contributor.swslhdauthorKelly, Ayano-
dc.contributor.swslhdauthorBrady, Bernadette-
dc.contributor.swslhdauthorFaasse, Kate-
dc.contributor.swslhdauthorEl-Haddad, Carlos-
dc.contributor.swslhdauthorFrade, Stephanie-
dc.description.affiliatesRheumatology department, Liverpool Hospital, Liverpool, NSW, Australia University of NSW, Sydney, Australia Western Sydney University, Sydney, Australia-
dc.identifier.doi10.1016/j.pec.2023.107996-
dc.identifier.departmentLiverpool Hospital, Department of Rheumatology-
dc.type.studyortrialArticle-
dc.identifier.journaltitlePatient Education and Counseling-
Appears in Collections:Liverpool Hospital

Files in This Item:
There are no files associated with this item.


Items in Prosentient are protected by copyright, with all rights reserved, unless otherwise indicated.

Google Media

Google ScholarTM

Who's citing